{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:52:46Z","timestamp":1791190366687,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005188","name":"Tobacco-Related Disease Research Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005188","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["DA011946"],"award-info":[{"award-number":["DA011946"]}]},{"name":"National Institute on Drug Abuse, National Institutes of Health"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.neuropharm.2012.04.010","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T22:23:38Z","timestamp":1335047018000},"page":"12-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Metabotropic glutamate 7 (mGlu7) receptor: A target for medication development for the treatment of cocaine dependence"],"prefix":"10.1016","volume":"66","author":[{"given":"Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xiong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.04.010_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0703904","article-title":"Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges","volume":"132","author":"Attucci","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib2","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neuropharm.2007.12.009","article-title":"Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated","volume":"54","author":"Ayala","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib4","article-title":"Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats","author":"Bahi","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib6","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1523\/JNEUROSCI.0176-04.2004","article-title":"Preferential effects of the metabotropic glutamate 2\/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer","volume":"24","author":"Baptista","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0022-3565(24)37122-8","article-title":"Synergistic effects of cocaine with lateral hypothalamic brain stimulation reward: lack of tolerance or sensitization","volume":"283","author":"Bauco","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0306-4522(94)90471-5","article-title":"Synaptic input and output of parvalbumin-immunoreactive neurons in the neostriatum of the rat","volume":"62","author":"Bennett","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib9","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1517\/13543784.9.10.2233","article-title":"Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders","volume":"9","author":"Bisaga","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib10","doi-asserted-by":"crossref","first-page":"10726","DOI":"10.1523\/JNEUROSCI.3207-04.2004","article-title":"A\u00a0role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking","volume":"24","author":"Bossert","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2005.09.030","article-title":"Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications","volume":"526","author":"Bossert","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib12","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1523\/JNEUROSCI.16-06-02044.1996","article-title":"Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies","volume":"16","author":"Bradley","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1471-4159.1998.71020636.x","article-title":"Distribution and developmental regulation of metabotropic glutamate receptor 7a in rat brain","volume":"71","author":"Bradley","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pbb.2011.11.006","article-title":"The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling","volume":"101","author":"Bradley","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib15","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1523\/JNEUROSCI.1497-06.2006","article-title":"Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice","volume":"26","author":"Callaerts-Vegh","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib16","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1523\/JNEUROSCI.16-09-03112.1996","article-title":"Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex","volume":"16","author":"Carlezon","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nn0901-873","article-title":"Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice","volume":"4","author":"Chiamulera","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1523\/JNEUROSCI.06-03-00613.1986","article-title":"Stimulation of the lateral habenula inhibits dopamine-containing neurons in the substantia nigra and ventral tegmental area of the rat","volume":"6","author":"Christoph","year":"1986","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1073\/pnas.0510051103","article-title":"mGluR7\u2019s lucky number","volume":"103","author":"Conn","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib21","doi-asserted-by":"crossref","first-page":"RC89","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","article-title":"Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction","volume":"20","author":"Cornish","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib22","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1460-9568.2003.02667.x","article-title":"Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7","volume":"17","author":"Cryan","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/cercor\/12.9.961","article-title":"Enrichment of mGluR7a in the presynaptic active zones of GABAergic and non-GABAergic terminals on interneurons in the rat somatosensory cortex","volume":"12","author":"Dalezios","year":"2002","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0028-3908(03)00052-2","article-title":"Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors","volume":"44","author":"David","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/FBP.0b013e32832ec5d1","article-title":"The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat","volume":"20","author":"Dolan","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","article-title":"Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure","volume":"189","author":"Epstein","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/sj.mp.4002073","article-title":"mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity","volume":"13","author":"Fendt","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00441-006-0266-5","article-title":"Metabotropic glutamate receptors","volume":"326","author":"Ferraguti","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib29","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1460-9568.1998.00133.x","article-title":"Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat","volume":"10","author":"Floresco","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib30","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1523\/JNEUROSCI.21-13-04915.2001","article-title":"Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons","volume":"21","author":"Floresco","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib32","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1523\/JNEUROSCI.0012-07.2007","article-title":"Glutamatergic afferents of the ventral tegmental area in the rat","volume":"27","author":"Geisler","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.109.162115","article-title":"Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson\u2019s disease","volume":"332","author":"Greco","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0079-6123(08)61883-X","article-title":"The nucleus accumbens: gateway for limbic structures to reach the motor system?","volume":"107","author":"Groenewegen","year":"1996","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00213-001-0953-6","article-title":"Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats","volume":"160","author":"Harrison","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.134.3483.943","article-title":"Progressive ratio as a measure of reward strength","volume":"134","author":"Hodos","year":"1961","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(24)38151-0","article-title":"The regulation of dopamine transmission by metabotropic glutamate receptors","volume":"289","author":"Hu","year":"1999","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib39","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/npp.2010.82","article-title":"The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats","volume":"35","author":"Jin","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2826.2001.00678.x","article-title":"Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists","volume":"13","author":"Johnson","year":"2001","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib41","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2005.02.005","article-title":"Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission","volume":"45","author":"Kalivas","year":"2005","journal-title":"Neuron"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2012.04.010_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamate transmission in addiction","volume":"56","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-003-1441-y","article-title":"The validity of the reinstatement model of craving and relapse to drug use","volume":"168","author":"Katz","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1196\/annals.1300.040","article-title":"Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats","volume":"1003","author":"Kenny","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-004-2069-2","article-title":"Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats","volume":"179","author":"Kenny","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H","article-title":"Reduced glutamate immunolabeling in the nucleus accumbens following extended withdrawal from self-administered cocaine","volume":"30","author":"Keys","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2008.12.003","article-title":"Glutamate and reinstatement","volume":"9","author":"Knackstedt","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and molecular mechanisms of drug dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neubiorev.2003.11.014","article-title":"Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse","volume":"27","author":"Kornetsky","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1096-9861(19991213)415:2<266::AID-CNE9>3.0.CO;2-7","article-title":"Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia","volume":"415","author":"Kosinski","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-002-1296-7","article-title":"Alterations in nerve terminal glutamate immunoreactivity in the nucleus accumbens and ventral tegmental area following single and repeated doses of cocaine","volume":"165","author":"Kozell","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00200-0","article-title":"Neurobiology of relapse to alcohol in rats","volume":"94","author":"Le","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1527-3458.2006.00149.x","article-title":"Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP","volume":"12","author":"Lea","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib57","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neuropharm.2007.11.005","article-title":"The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats","volume":"54","author":"Li","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib58","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/npp.2008.236","article-title":"Metabotropic glutamate receptor 7 modulates the rewarding effects of cocaine in rats: involvement of a ventral pallidal GABAergic mechanism","volume":"34","author":"Li","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib59","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1471-4159.2010.06851.x","article-title":"Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2\/3 mechanism in rats","volume":"114","author":"Li","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib60","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bcp.2007.05.020","article-title":"Metabotropic glutamate 2\/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats","volume":"74","author":"Liechti","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib61","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00023210-200822090-00001","article-title":"Role of the glutamatergic system in nicotine dependence: implications for the discovery and development of new pharmacological smoking cessation therapies","volume":"22","author":"Liechti","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib62","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1523\/JNEUROSCI.1766-07.2007","article-title":"Metabotropic glutamate 2\/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence","volume":"27","author":"Liechti","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib63","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1523\/JNEUROSCI.0299-07.2007","article-title":"Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson\u2019s disease","volume":"27","author":"Lopez","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(00)00633-6","article-title":"Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: an in\u00a0vivo microdialysis study","volume":"404","author":"Mao","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/jn.00356.2007","article-title":"Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception","volume":"98","author":"Marabese","year":"2007","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2005.09.006","article-title":"Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors","volume":"6","author":"Marino","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopsych.2006.03.053","article-title":"Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?","volume":"61","author":"Markou","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1358\/dnp.2007.20.2.1083435","article-title":"The role of metabotropic glutamate receptors in drug reward, motivation and dependence","volume":"20","author":"Markou","year":"2007","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0031-9384(92)90211-J","article-title":"Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations","volume":"51","author":"Markou","year":"1992","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02244907","article-title":"Animal models of drug craving","volume":"112","author":"Markou","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib71","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<211::AID-SYN11>3.0.CO;2-4","article-title":"Cocaine-induced changes in glutamate and GABA immunolabeling within rat habenula and nucleus accumbens","volume":"30","author":"Meshul","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib73","doi-asserted-by":"crossref","first-page":"18712","DOI":"10.1073\/pnas.0508063102","article-title":"A\u00a0selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in\u00a0vivo","volume":"102","author":"Mitsukawa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib74","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/sj.npp.1300926","article-title":"Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders","volume":"31","author":"Mitsukawa","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A\u00a0new benzodiazepine pharmacology","volume":"300","author":"Mohler","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2010.01.030","article-title":"Group II metabotropic glutamate receptors (mGlu2\/3) in drug addiction","volume":"639","author":"Moussawi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2005.06.018","article-title":"Critical assessment of how to study addiction and its treatment: human and non-human animal models","volume":"108","author":"O\u2019Brien","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1874473710902010083","article-title":"Metabotropic glutamate receptor ligands as potential therapeutics for addiction","volume":"2","author":"Olive","year":"2009","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib80","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.neuroscience.2007.02.016","article-title":"Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources","volume":"146","author":"Omelchenko","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2008.03.017","article-title":"Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain","volume":"139","author":"Osikowicz","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib82","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neuropharm.2008.05.007","article-title":"Group III mGluR7 and mGluR8 in the amygdala differentially modulate nocifensive and affective pain behaviors","volume":"55","author":"Palazzo","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib83","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-007-0856-2","article-title":"Activation of the mGlu7 receptor elicits antidepressant-like effects in mice","volume":"194","author":"Palucha","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib84","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1124\/jpet.110.169730","article-title":"The antidepressant-like action of metabotropic glutamate 7 receptor agonist N, N\u2019-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent","volume":"334","author":"Palucha-Poniewiera","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib85","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1523\/JNEUROSCI.16-04-01550.1996","article-title":"Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization","volume":"16","author":"Pierce","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib87","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pbb.2008.06.006","article-title":"Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082","volume":"91","author":"Salling","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-3057(76)90178-7","article-title":"Rate-dependent effects of drugs: a review of the literature","volume":"4","author":"Sanger","year":"1976","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib92","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib93","first-page":"935","article-title":"Role of metabotropic glutamate receptors in animal models of Parkinson\u2019s disease","volume":"55","author":"Senkowska","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib94","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1196\/annals.1300.066","article-title":"Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions","volume":"1003","author":"Sesack","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.54.1.1","article-title":"Neurobiology of relapse to heroin and cocaine seeking: a review","volume":"54","author":"Shalev","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/381523a0","article-title":"Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone","volume":"381","author":"Shigemoto","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib98","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1523\/JNEUROSCI.17-19-07503.1997","article-title":"Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus","volume":"17","author":"Shigemoto","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib99","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1006\/bbrc.2001.4703","article-title":"xCt cystine transporter expression in HEK293 cells: pharmacology and localization","volume":"282","author":"Shih","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib100","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/WNR.0b013e328307f295","article-title":"Amygdaloid metabotropic glutamate receptor subtype 7 is involved in the acquisition of conditioned fear","volume":"19","author":"Siegl","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib101","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/FBP.0b013e32830cd839","article-title":"Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission","volume":"19","author":"Stachowicz","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib102","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/jpet.110.177378","article-title":"The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?","volume":"338","author":"Sukoff Rizzo","year":"2011","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.107.124701","article-title":"In\u00a0vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists","volume":"323","author":"Suzuki","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib104","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0028-3908(96)84635-1","article-title":"alpha-Methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists","volume":"35","author":"Thomas","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nn757","article-title":"Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine","volume":"4","author":"Thomas","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib106","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.107.130310","article-title":"Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement","volume":"325","author":"Torregrossa","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib107","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2008.04.016","article-title":"The glutamatergic projection from the prefrontal cortex to the nucleus accumbens core is required for cocaine-induced decreases in ventral pallidal GABA","volume":"438","author":"Torregrossa","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib108","article-title":"Pharmacological interference with metabotropic glutamate receptor subtype 7 but not subtype 5 differentially affects within- and between-session extinction of Pavlovian conditioned fear","author":"Toth","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib109","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.mp.4001269","article-title":"Glutamatergic mechanisms in addiction","volume":"8","author":"Tzschentke","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.010_bib110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","article-title":"Addictive drugs and brain stimulation reward","volume":"19","author":"Wise","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(96)80079-1","article-title":"Neurobiology of addiction","volume":"6","author":"Wise","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib112","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","article-title":"A\u00a0psychomotor stimulant theory of addiction","volume":"94","author":"Wise","year":"1987","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2009.09.101","article-title":"A\u00a0ventral tegmental CRF-glutamate-dopamine interaction in addiction","volume":"1314","author":"Wise","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib114","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1874473710801030303","article-title":"Hypothesis-driven medication discovery for the treatment of psychostimulant addiction","volume":"1","author":"Xi","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/jpet.102.039735","article-title":"Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine","volume":"303","author":"Xi","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib116","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1046\/j.1471-4159.2003.02093.x","article-title":"Inhibition of non-vesicular glutamate release by group III metabotropic glutamate receptors in the nucleus accumbens","volume":"87","author":"Xi","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib117","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","article-title":"Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens","volume":"26","author":"Xi","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib118","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1471-4159.2009.06478.x","article-title":"Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2\/3-mediated mechanism","volume":"112","author":"Xi","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib119","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2174\/1568026054750272","article-title":"Agonists and antagonists for group III metabotropic glutamate receptors 6, 7 and 8","volume":"5","author":"Yang","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2012.04.010_bib120","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1523\/JNEUROSCI.2384-06.2006","article-title":"Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala","volume":"26","author":"Zhao","year":"2006","journal-title":"J.\u00a0Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T08:04:47Z","timestamp":1742976287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":120,"alternative-id":["S0028390812001463"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.04.010","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabotropic glutamate 7 (mGlu7) receptor: A target for medication development for the treatment of cocaine dependence","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}